Our Team
Gerald L. Klein, MD
Principal
Dr. Klein is an Adjunct Professor of Pharmacology & Toxicology in the Brody School of Medicine at East Carolina University. In addition, he has been the founder of an SMO, CRO, Medical Writing Company, Analytic Lab, GI Biotherapeutics company, and a physician consulting company. Dr. Klein is a senior advisor to Technomark Life Sciences (a venture capital company).
Dr. Roger E. Morgan, MD, FACS
Vice-President, Medical affairs
Dr. Roger E. Morgan, MD, FACS, has extensive experience in global medical affairs with both pharmaceutical companies and CROs. While trained as a surgeon/critical care intensivist, he spent much of his industry career focused on metabolic and cardiovascular research.
Peter C. Johnson, MD
Principal
Dr. Johnson practiced reconstructive surgery for 10 years at the University of Pittsburgh where he founded and was the first President of the Pittsburgh Tissue Engineering Initiative.
Pavle Vukojevic, MD
VP of Product Development and Medical Affairs Europe
Dr. Vukojevic is an experienced medical/scientific clinical development professional at the global level with extensive knowledge of international drug development processes and procedures including within the U.S., EU countries, non-EU countries, Commonwealth of Independent States (CIS), and India.
Shabnam Vaezzadeh, MD, MPA, BCMS
VP of Product Development and Medical Affairs Canada
Dr Vaezzadeh has over 20 years of experience in the medical industry, holding senior corporate leadership roles in Medical Affairs, Clinical Development and Safety, and involvement in business development.
Shengjun (Shane) Zhang
VP of asia
Dr. Zhang has over three decades of experience in clinical and foundational research bridging the realms of both China and the USA.